Photocure Cash Flow Conversion Efficiency

Latest as of June 2026: 0.103x

Photocure cash flow conversion efficiency. Based on the latest financial reports, Photocure (PHO) has a cash flow conversion efficiency ratio of 0.103x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr62.78 Million ≈ $6.61 Million USD) by net assets (Nkr606.75 Million ≈ $63.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Photocure (2002–2025)

Cash flow conversion efficiency of Photocure from 2002 to 2025. This chart illustrates how Photocure's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PHO share price today for real-time trading data and today's change.

Photocure Cash Flow Conversion Ratio Explained

Photocure cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Photocure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Photocure ranked by their cash flow conversion efficiency. Also see market value of Photocure for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Varia US Properties Ltd
SW:VARN
0.018x
Rawlplug S.A.
WAR:RWL
0.070x
Lan Fa Textile Co Ltd
TW:1459
0.028x
Forrester Research Inc
NASDAQ:FORR
-0.030x
Bank Artha Graha Internasional
JK:INPC
0.010x
Bukaka Teknik Utama Tbk Pt
JK:BUKK
0.033x
Fate Therapeutics Inc
NASDAQ:FATE
-0.104x
Astec LifeSciences Limited
NSE:ASTEC
-0.020x

Annual Cash Flow Conversion Efficiency for Photocure (2002–2025)

The table below shows the annual cash flow conversion efficiency of Photocure from 2002 to 2025. Review Photocure (PHO) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr484.23 Million
≈ $50.96 Million
Nkr25.96 Million
≈ $2.73 Million
0.054x -64.96%
2024-12-31 Nkr501.72 Million
≈ $52.79 Million
Nkr76.75 Million
≈ $8.08 Million
0.153x +151.36%
2023-12-31 Nkr482.85 Million
≈ $50.81 Million
Nkr29.39 Million
≈ $3.09 Million
0.061x +1495.53%
2022-12-31 Nkr462.73 Million
≈ $48.69 Million
Nkr-2.02 Million
≈ $-212.35K
-0.004x -109.18%
2021-12-31 Nkr502.63 Million
≈ $52.89 Million
Nkr23.89 Million
≈ $2.51 Million
0.048x +54.94%
2020-12-31 Nkr508.13 Million
≈ $53.47 Million
Nkr15.59 Million
≈ $1.64 Million
0.031x -69.03%
2019-12-31 Nkr208.59 Million
≈ $21.95 Million
Nkr20.66 Million
≈ $2.17 Million
0.099x +172.38%
2018-12-31 Nkr176.34 Million
≈ $18.56 Million
Nkr-24.12 Million
≈ $-2.54 Million
-0.137x -26.45%
2017-12-31 Nkr218.08 Million
≈ $22.95 Million
Nkr-23.59 Million
≈ $-2.48 Million
-0.108x -242.01%
2016-12-31 Nkr251.94 Million
≈ $26.51 Million
Nkr19.19 Million
≈ $2.02 Million
0.076x +176.09%
2015-12-31 Nkr210.06 Million
≈ $22.10 Million
Nkr-21.03 Million
≈ $-2.21 Million
-0.100x -294.80%
2014-12-31 Nkr240.06 Million
≈ $25.26 Million
Nkr-6.09 Million
≈ $-640.63K
-0.025x +93.16%
2013-12-31 Nkr269.12 Million
≈ $28.32 Million
Nkr-99.72 Million
≈ $-10.49 Million
-0.371x -156.53%
2012-12-31 Nkr380.27 Million
≈ $40.02 Million
Nkr-54.93 Million
≈ $-5.78 Million
-0.144x -84.12%
2011-12-31 Nkr439.34 Million
≈ $46.23 Million
Nkr-34.47 Million
≈ $-3.63 Million
-0.078x -330.80%
2010-12-31 Nkr458.85 Million
≈ $48.28 Million
Nkr15.60 Million
≈ $1.64 Million
0.034x -95.55%
2009-12-31 Nkr415.78 Million
≈ $43.75 Million
Nkr317.44 Million
≈ $33.40 Million
0.763x +355.48%
2008-12-31 Nkr199.69 Million
≈ $21.01 Million
Nkr-59.68 Million
≈ $-6.28 Million
-0.299x +18.77%
2007-12-31 Nkr259.99 Million
≈ $27.36 Million
Nkr-95.66 Million
≈ $-10.07 Million
-0.368x -281.35%
2006-12-31 Nkr326.94 Million
≈ $34.40 Million
Nkr66.33 Million
≈ $6.98 Million
0.203x +113.94%
2005-12-31 Nkr48.47 Million
≈ $5.10 Million
Nkr-70.54 Million
≈ $-7.42 Million
-1.455x -147.85%
2004-12-31 Nkr85.57 Million
≈ $9.00 Million
Nkr-50.25 Million
≈ $-5.29 Million
-0.587x -9.86%
2003-12-31 Nkr131.90 Million
≈ $13.88 Million
Nkr-70.51 Million
≈ $-7.42 Million
-0.535x -75.36%
2002-12-31 Nkr167.00 Million
≈ $17.57 Million
Nkr-50.91 Million
≈ $-5.36 Million
-0.305x --

About Photocure

OL:PHO Norway Drug Manufacturers - Specialty & Generic
Market Cap
$131.57 Million
Nkr1.25 Billion NOK
Market Cap Rank
#17978 Global
#154 in Norway
Share Price
Nkr46.45
Change (1 day)
-0.54%
52-Week Range
Nkr46.45 - Nkr79.00
All Time High
Nkr150.90
About

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and Development Portfolio. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination pro… Read more